secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hoth Therapeutics, Inc. (HOTH)
CIK:        0001711786
Form:       8-K
Filed at:   2023-08-21T23:59:59+00:00
Accession:  0001213900-23-069494
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Hoth Therapeutics shareholders re-elect all five directors, approve auditor and equity plan at 2023 annual meeting
--------------------------------------------------------------------------------

- All five nominees (Robb Knie, David Sarnoff, Graig Springer, Wayne Linsley, Jeff Pavell) elected to board with large majority of votes cast.
- Ratification of Withum Smith+Brown as independent auditor for FY2023 approved: 1,111,058 for, 158,230 against, 54,787 abstain.
- Hoth Therapeutics Amended and Restated 2022 Omnibus Equity Incentive Plan approved: 190,903 for, 112,224 against, 27,459 abstain, 993,489 broker non-votes.
- Total shares voted: 1,324,075, representing a quorum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711786/000121390023069494/0001213900-23-069494-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711786/000121390023069494/ea183965-8k_hoththera.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-069494

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer